These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
825 related articles for article (PubMed ID: 15196571)
1. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571 [TBL] [Abstract][Full Text] [Related]
2. [Antagonistic interaction between Clostridium butyricum and enterohemorrhagic Escherichia coli O157:H7]. Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Sakazaki R; Kamiya S Kansenshogaku Zasshi; 1999 Jan; 73(1):7-14. PubMed ID: 10077896 [TBL] [Abstract][Full Text] [Related]
3. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798 [TBL] [Abstract][Full Text] [Related]
4. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains. Yoshimura K; Matsui T; Itoh K Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297 [TBL] [Abstract][Full Text] [Related]
5. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570 [TBL] [Abstract][Full Text] [Related]
6. Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7. Momose Y; Hirayama K; Itoh K Antonie Van Leeuwenhoek; 2008 Aug; 94(2):165-71. PubMed ID: 18247153 [TBL] [Abstract][Full Text] [Related]
7. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. Carey CM; Kostrzynska M; Ojha S; Thompson S J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583 [TBL] [Abstract][Full Text] [Related]
9. [New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157]. Karch H; Köhler B Gesundheitswesen; 1999 Oct; 61 Spec No 1():S46-51. PubMed ID: 10593045 [TBL] [Abstract][Full Text] [Related]
10. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins. Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616 [TBL] [Abstract][Full Text] [Related]
11. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection. Cai K; Gao X; Li T; Wang Q; Hou X; Tu W; Xiao L; Tian M; Liu Y; Wang H Vaccine; 2011 Jan; 29(5):946-52. PubMed ID: 21134452 [TBL] [Abstract][Full Text] [Related]
12. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli. Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057 [TBL] [Abstract][Full Text] [Related]
13. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches. Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888 [TBL] [Abstract][Full Text] [Related]
14. Detection of enterohemorrhagic Escherichia coli O157:H7 by using a multiplex real-time PCR assay for genes encoding intimin and Shiga toxins. Sharma VK; Dean-Nystrom EA Vet Microbiol; 2003 May; 93(3):247-60. PubMed ID: 12695048 [TBL] [Abstract][Full Text] [Related]
15. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle. Baker DR; Moxley RA; Steele MB; Lejeune JT; Christopher-Hennings J; Chen DG; Hardwidge PR; Francis DH Appl Environ Microbiol; 2007 Nov; 73(22):7338-46. PubMed ID: 17890332 [TBL] [Abstract][Full Text] [Related]
17. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli in white veal calves. Cristancho L; Johnson RP; McEwen SA; Gyles CL Vet Microbiol; 2008 Jan; 126(1-3):200-9. PubMed ID: 17656044 [TBL] [Abstract][Full Text] [Related]
18. Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice. Rahal EA; Kazzi N; Kanbar A; Abdelnoor AM; Matar GM Int J Antimicrob Agents; 2011 Feb; 37(2):135-9. PubMed ID: 21129928 [TBL] [Abstract][Full Text] [Related]
19. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli. Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158 [TBL] [Abstract][Full Text] [Related]
20. Detection of Shiga toxin genes stx1, stx2, and the +93 uidA mutation of E. coli O157:H7/H-using SYBR Green I in a real-time multiplex PCR. Yoshitomi KJ; Jinneman KC; Weagant SD Mol Cell Probes; 2006 Feb; 20(1):31-41. PubMed ID: 16271448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]